{"id":224537,"date":"2023-06-30T00:00:00","date_gmt":"2023-06-30T00:00:00","guid":{"rendered":"http:\/\/clarivate.com\/life-sciences-healthcare\/report\/47041116-medtech-interventional-cardiology-devices-market\/"},"modified":"2026-04-29T05:03:29","modified_gmt":"2026-04-29T05:03:29","slug":"47041116-medtech-interventional-cardiology-devices-market-insights-europe-part-2","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47041116-medtech-interventional-cardiology-devices-market-insights-europe-part-2\/","title":{"rendered":"Interventional Cardiology Devices &#8211; Market Insights &#8211; Europe Part 2"},"content":{"rendered":"<p>With the impact of, and recovery from, the <abbr title=\"Coronavirus Disease 2019\">COVID-19<\/abbr> pandemic coming to an end, the European <abbr title=\"Interventional Cardiology\">IC<\/abbr> device market will shortly witness a return to prepandemic growth trends. Shifting preference toward several new approaches, such as <abbr title=\"Fractional Flow Reserve\">FFR<\/abbr>, <abbr title=\"Intravascular Ultrasound\">IVUS<\/abbr>, <abbr title=\"Drug-Coated Balloon\">DCB<\/abbr>s for complex <abbr title=\"Percutaneous Coronary Intervention\">PCI<\/abbr>s, specialty balloons, and radial access approaches, along with new positive clinical, will fuel market growth in the European <abbr title=\"Interventional Cardiology\">IC<\/abbr> device market, thus impacting the position of the current market leaders going forward.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the state of the market for <abbr title=\"Interventional Cardiology\">IC<\/abbr> devices in Europe from 2019 through 2032.<\/p>\n<p class=\"question-statement\"><strong>The <abbr title=\"Drug-Eluting Stent(s)\">DES<\/abbr> segment is a highly competitive space, with the leading companies continuing to launch updates to their flagship devices.<\/strong><\/p>\n<p>Has there been any change in position between the three major competitors in the highly lucrative <abbr title=\"Drug-Eluting Stent(s)\">DES<\/abbr> device market?<\/p>\n<p>What competitive strategies are the major competitors implementing to gain share in this market?<\/p>\n<p>How will <abbr title=\"Bioresorbable Scaffold(s)\">BRS<\/abbr> development impact the coronary stent market over the forecast period?<\/p>\n<p class=\"question-statement\"><strong>Emerging technologies designed to diagnose and treat complex <abbr title=\"Percutaneous Coronary Intervention\">PCI<\/abbr>s will influence the <abbr title=\"Interventional Cardiology\">IC<\/abbr> device market landscape in Europe.<\/strong><\/p>\n<p class=\"question-statement\">How are <abbr title=\"Drug-Coated Balloon\">DCB<\/abbr>s going to be adopted going forward?<\/p>\n<p class=\"question-statement\">What is the impact of the latest generation of alternative coronary physiology modalities such as resting index or imaging-based <abbr title=\"Fractional Flow Reserve\">FFR<\/abbr><sub>angio<\/sub> and <abbr title=\"Fractional Flow Reserve\">FFR<\/abbr><sub><abbr title=\"Computed Tomography\">CT<\/abbr><\/sub> on the patient and procedure in cardiac catheterization labs?<\/p>\n<p class=\"question-statement\">How will recent clinical evidence impact the adoption of <abbr title=\"Intravascular Ultrasound\">IVUS<\/abbr> and <abbr title=\"Optical Coherence Tomography\">OCT<\/abbr>?<\/p>\n<p class=\"question-statement\">How will the emergence of alternative <abbr title=\"Fractional Flow Reserve\">FFR<\/abbr> modalities affect the <abbr title=\"Fractional Flow Reserve\">FFR<\/abbr> pressure guidewire market?<\/p>\n<p>What is the status and expected impact of emerging techniques like coronary lithotripsy?<\/p>\n<p>How will this impact the small and mid-sized emerging companies in the <abbr title=\"Interventional Cardiology\">IC<\/abbr> device market?<\/p>\n<p><b>The European<strong> <\/strong><abbr title=\"Interventional Cardiology\">IC<\/abbr> device market has been impacted by the <abbr title=\"Coronavirus Disease 2019\">COVID-19<\/abbr> pandemic.<\/b><\/p>\n<p>What is the recovery outlook for 2022 and going forward?<\/p>\n","protected":false},"template":"","class_list":["post-224537","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-cardiovascular","medtech-therapy-area-interventional-cardiology-devices","medtech-geography-europe","medtech-date-976"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/224537","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/224537\/revisions"}],"predecessor-version":[{"id":281581,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/224537\/revisions\/281581"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=224537"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}